版本:
中国

BRIEF-Emergent Biosolutions signs $53 mln modification to Barda contract for manufacture of botulism antitoxin

March 31 Emergent Biosolutions Inc

* Emergent Biosolutions signs $53 million modification to Barda contract for the manufacture of botulism antitoxin

* Emergent Biosolutions - modification to contract will enable future filling and deliveries of final drug product to strategic national stockpile Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐